Proton therapy not better than IMRT in lung cancer

The first randomised trial to compare proton therapy with conventional radiotherapy has not found a difference in toxicity, which is the main claim for superiority of proton therapy. The trial was conducted in patients with inoperable non-small cell lung cancer and showed that proton therapy was not superior in reducing serious lung toxicity compared with intensity-modulated radiotherapy.